Blog

Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials

Luca Arecco/X

Apr 5, 2025, 05:36

Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials

Luca Arecco, Clinical Research Fellow at ESMO, posted on X about recent paper he and colleagues co-authored:

“Published in Journal of the National Cancer Institute (JNCI) our analysis assessing the prognosis of patients considered at high risk of recurrence according to monarchE and NATALEE trials inclusion criteria!”

“Prognostic implications of risk definitions from the monarchE and NATALEE trials.”

Authors: Luca Arecco, Eva Blondeaux, Marco Bruzzone, Grazia Arpino, Carmine De Angelis, Michelino De Laurentiis, Roberta Caputo, Alessandra Fabi, Valeria Sanna, Stefania Gori, Fabio Puglisi, Luca Boni, Simone Nardin, Irene Giannubilo, Marta Perachino, Roberto Borea, Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini, Lucia Del Mastro

cancer Carmine De Angelis Eva Blondeaux Grazia Arpino JNCI Luca Arecco Marco Bruzzone Michelino De Laurentiis monarchE trial NATALEE trial OncoDaily Oncology Roberta Caputo

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia